Skip Navigation



Rheumatology Advance Access published online on May 30, 2003

Rheumatology, doi:10.1093/rheumatology/keg322
Rheumatology © British Society for Rheumatology 2003; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
42/10/1183    most recent
keg322v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cruz, B. A.
Right arrow Articles by Guillevin, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruz, B. A.
Right arrow Articles by Guillevin, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Rheumatology 42 © British Society for Rheumatology 2003; all rights reserved

Original Papers

Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit

B. A. Cruz 1, J. Ramanoelina 1, A. Mahr 1, P. Cohen 1, L. Mouthon 1, Y. Cohen 2, P. Hoang 2, L. Guillevin 1*

1 Department of Internal Medicine, UPRES EA-3409 Recherche Clinique et Thérapeutique, Université Paris-Nord, Bobigny, France
2 Intensive Care Unit, Hôpital Avicenne, Assistance Publique des Hôpitaux de Paris, Université Paris-Nord, Bobigny, France

* Corresponding author. E-mail: loic.guillevin{at}avc.ap.

Received 30 November 2002 ; accepted 17 February 2003

Abstract

Objectives. To investigate presenting features, prognostic factors and outcomes of patients with systemic necrotizing vasculitis (SNV) admitted to the intensive care unit (ICU).

Methods. We retrospectively reviewed the medical records of all 210 SNV patients followed in our university hospital and admitted to the ICU between 1982 and 2001, with respect to clinical features, ICU disease severity scores (APACHE II and SAPS II), the Birmingham vasculitis activity score (BVAS), the five-factors score (FFS) and outcomes.

Results. Twenty-six patients (16 men, 10 women) with a mean age of 46.3±16.5 yr were included. The reasons for ICU admission were: active SNV, 20 (77%); infection, 3 (12%); others, 3 (12%). SNV was diagnosed in 11 (42%) patients in the ICU. The mean APACHE II and SAPS II scores were significantly higher for patients who died in the ICU (P = 0.01 and P = 0.01 respectively). After a mean follow-up of 31.4±29.2 months, the overall mortality rate was 39% (10 patients). Among patients admitted to the ICU with active SNV, BVAS calculated at ICU admission was significantly higher for non-survivors at the end of follow-up (26.9±13.0 vs 14.7±4.6, P = 0.02).

Conclusion. The main reason for admitting SNV patients to the ICU was active vasculitis, which was often the first manifestation of SNV and led to its diagnosis. ICU disease severity scores at admission were associated with mortality in the ICU but did not predict long-term outcome, unlike BVAS, which accurately predicted long-term outcome but not ICU prognosis for patients admitted to the ICU with active SNV.

Key words: Systemic vasculitis, Intensive care unit, Outcome, Prognosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
J F Camargo, G J Tobon, N Fonseca, J L Diaz, M Uribe, F Molina, and J-M Anaya
Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature
Lupus, April 1, 2005; 14(4): 315 - 320.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.